Investigating the blood-brain barrier - physiology, pathology and applications

 

A one day meeting to be held on Tuesday 17 July 2007at The BioPark Hertfordshire, Broadwater Road, WelwynGarden City, Hertfordshire AL7 3AX

 

For more information see http://www.regonline.co.uk/bloodbrain07

 

The blood-brain barrier (BBB) is composed of specialised endothelium which physically separates the central nervous system from brain microvasculature, and prevents movement of many substances between the two. Only a very limited number of molecules are able to cross the BBB including those that are lipid soluble, those for which there are specific transport systems and small molecular weight molecules (below about 500 Daltons), making drug delivery to the brain a real challenge. The aim of this meeting is to provide an update on BBB endothelial cell (patho)physiology and function and to discuss novel approaches CNS drug delivery.

Dr Charlotte Lawson, Royal Veterinary College (Meeting Chair)

 

Confirmed talk
Lymphocyte-mediated endothelial cell signalling pathways modulate blood-brain barrier functionProfessor Greenwood,
Institute of Ophthalmology, UCL.London

Confirmed Speaker

Professor Anne Ridley, Ludwig Institute for Cancer Research, London, UK

 

 

Early Registration fees (deadline April 20th, after which the fees double)

 

  • Standard fee - £249
  • Academic fee - £149
  • Student fee - £99
  • IBMS members fee - £149


Abstracts

 

Abstracts will be accepted for oral or poster presentation and will be published in the meeting proceedings.

The deadline for abstract submissions is April 10th 2007.

Guidelines can be found at http://www.euroscicon.com/absguidlines.html

 

 

Contact details

 

Email: enquiries@euroscicon.com

Web: www.euroscicon.com

 

 

 We seek CPD accreditation from the IBMS for all our meetings

 

Investigating the blood-brain barrier - physiology, pathology and applications: 17 July 2007